<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVES: To review the results of a 13-year surveillance programme of patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> to determine the incidence of <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>Although the risk of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> in <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> is well established, the magnitude of this risk is still controversial </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: Records of <z:hpo ids='HP_0000001'>all</z:hpo> patients with histologically confirmed <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> in our 13-year surveillance programme were examined retrospectively </plain></SENT>
<SENT sid="3" pm="."><plain>SETTING: Integrated gastroenterology and gastrointestinal surgical service in a large teaching hospital </plain></SENT>
<SENT sid="4" pm="."><plain>PARTICIPANTS: During the study period, 597 patients had a diagnosis of <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e>; of these, 357 entered a yearly endoscopy and biopsy surveillance programme </plain></SENT>
<SENT sid="5" pm="."><plain>MAIN OUTCOME MEASURES: The development of oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: After a mean follow-up of 43 months, 12 patients, <z:hpo ids='HP_0000001'>all</z:hpo> with specialized epithelium, developed <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (11 men), an incidence for men of one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> per 69 patient-years; and for women, one <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> per 537 patient-years follow-up (P &lt; 0.01) </plain></SENT>
<SENT sid="7" pm="."><plain>If only patients with specialized mucosa were included the incidence of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> was one per 95 patient-years of follow-up (men, one per 61 patient-years; women, one per 468 patient-years) </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSIONS: Whilst the role of screening patients with <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> remains controversial, this study supports the routine surveillance of male patients with specialized epithelium </plain></SENT>
</text></document>